Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STEAP2 antisense RNA 1 (STEAP2-AS1)
- Target
- STEAP2-AS1
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
STEAP2-AS1 is a long non-coding RNA involved in regulating gene expression, potentially affecting cellular processes like proliferation and apoptosis, particularly in cancer development. It is located on chromosome 19 and has roles in modulating cancer-related pathways.
- Other names
- STEAP2 antisense RNA 1LINC00916
02
Mechanism of action
Regulates gene expression potentially through interactions with other RNA molecules or proteins.
03
Biological functions
Gene expression regulationCell proliferationApoptosis
04
Disease associations
Cancer
Beyond the preview
Go deeper on STEAP2 antisense RNA 1 (STEAP2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STEAP2 antisense RNA 1 (STEAP2-AS1).